Mass General researchers have become pivotal players in the emergence of precision medicine due to their local and international leadership in genomics.
Mass General researchers are using artificial-intelligence to analyze standard chest x-rays to predict patients’ future risk of a variety of disorders.
An infectious disease specialist at Mass General says vaccinations have made measles a rarity in the United States, although risks remain.
A Weissman Family MGH Research Scholar is exploring whether beauty salons in South Africa can help to prevent unwanted pregnancies and stop the spread of HIV.
The Neonatal Intensive Care Unit at the MassGeneral Hospital for Children has adopted a new process for transitioning premature infants to oral feeding.
A Mass General researcher is studying a rare, inherited form of ALS, aiming to diagnose the disease in its earliest stages and develop new treatments.
In search of how children develop severe allergies and autoimmune disorders, Nitya Jain, PhD, at MassGeneral Hospital for Children, is studying how the immune system’s T cells communicate with bacteria in the gut.
A clinician-investigator from Mass General’s Multiple Sclerosis Clinic discusses treatment options for MS patients and how research could help in diagnosing and monitoring the disease.
At Mass General, Scott Plotkin, MD, PhD, and Vijaya Ramesh, PhD, are using their respective expertise in clinical and fundamental science to investigate new treatments for neurofibromatosis and two related disorders.
A new initiative from the Department of Medicine at Mass General, the Pathways Service provides a way for medical residents to discuss unusual patient cases and initiate research projects based on the questions the cases raise.